Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Early research (Phase 1)Study completedNCT02493751
What this trial is testing

Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

Who this might be right for
Renal Cell Cancer
Pfizer 55
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Not applicableUnknownNCT02292914
What this trial is testing

Prospective Analysis of Robot-Assisted Surgery

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+7 more
Instituto do Cancer do Estado de São Paulo 1,120
Not applicableActive Not RecruitingNCT04960514
What this trial is testing

Prospective Decision Impact Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2+1 more
Renalytix AI, Inc. 2,000
Not applicableActive Not RecruitingNCT04467021
What this trial is testing

Cancer and Blood Pressure Management, CARISMA Study

Who this might be right for
Cardiovascular DisorderChronic Kidney DiseaseMetastatic Renal Cell Carcinoma+6 more
ECOG-ACRIN Cancer Research Group 61
Testing effectiveness (Phase 2)Study completedNCT00392821
What this trial is testing

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
SCRI Development Innovations, LLC 78
Testing effectiveness (Phase 2)Study completedNCT01277744
What this trial is testing

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

Who this might be right for
Advanced CancersSarcoma
M.D. Anderson Cancer Center 22
Not applicableWithdrawnNCT02778295
What this trial is testing

Biomarker for Patients With Fabry Disease (BioFabry)

Who this might be right for
AngiokeratomasChronic Kidney DiseaseOcular Abnormalities+1 more
CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Study completedNCT00661375
What this trial is testing

BAY43-9006 Phase II Study for Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Post-approval studies (Phase 4)Study completedNCT07270146
What this trial is testing

Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency

Who this might be right for
Mild and Moderate Oligozoospermia Asthenospermia or Oligoasthenospermia and the Syndrome Differentiation Type is Shen (Kidney) Essence Deficiency
DongE E Jiao Coporation Limited 360
Early research (Phase 1)Study completedNCT01853046
What this trial is testing

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Who this might be right for
Neoplasms
Bayer 24
Testing effectiveness (Phase 2)Ended earlyNCT00790842
What this trial is testing

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
PrECOG, LLC. 63
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Temporarily pausedNCT06860386
What this trial is testing

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 75
Testing effectiveness (Phase 2)UnknownNCT01274273
What this trial is testing

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Aarhus 118
Not applicableStudy completedNCT06761742
What this trial is testing

Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests

Who this might be right for
Renal Tumors
RenJi Hospital 1,922
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Next Page